The device, which is delivered transapically, represents an option for very sick patients who previously have had none.
Reaching participants through retail pharmacies, the study speaks to how much VHD goes underrecognized—with a few surprises.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback